IL82851A - נגיף ואריצלה - זוסטר שטבעו שונה, ייצורו ותרכיב המכיל אותו - Google Patents

נגיף ואריצלה - זוסטר שטבעו שונה, ייצורו ותרכיב המכיל אותו

Info

Publication number: IL82851A
Authority: IL; Israel
Prior art keywords: vzv; dna; pres; gene; recombinant
Prior art date: 1986-06-20

Application number

IL8285187A

Other languages

English (en)

Other versions

IL82851A0 (en

Original Assignee

Merck & Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-06-20

Filing date

1987-06-11

Publication date

1995-01-24

1987-06-11 Application filed by Merck & Co Inc filed Critical Merck & Co Inc

1987-12-20 Publication of IL82851A0 publication Critical patent/IL82851A0/xx

1995-01-24 Publication of IL82851A publication Critical patent/IL82851A/he

Links

241000701085 Human alphaherpesvirus 3 Species 0.000 title claims abstract description 151
229960005486 vaccine Drugs 0.000 title claims abstract description 17
238000004519 manufacturing process Methods 0.000 title claims description 10
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 20
229920001184 polypeptide Polymers 0.000 claims abstract description 18
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 18
201000006082 Chickenpox Diseases 0.000 claims abstract description 10
206010046980 Varicella Diseases 0.000 claims abstract description 10
244000052637 human pathogen Species 0.000 claims abstract description 7
230000002163 immunogen Effects 0.000 claims abstract description 6
244000052769 pathogen Species 0.000 claims abstract description 6
108020004414 DNA Proteins 0.000 claims description 48
108090000623 proteins and genes Proteins 0.000 claims description 46
241000701044 Human gammaherpesvirus 4 Species 0.000 claims description 34
101150087500 Gpl gene Proteins 0.000 claims description 26
108091026890 Coding region Proteins 0.000 claims description 23
102000004169 proteins and genes Human genes 0.000 claims description 21
230000002238 attenuated effect Effects 0.000 claims description 8
238000000034 method Methods 0.000 claims description 8
230000001717 pathogenic effect Effects 0.000 claims description 5
238000013518 transcription Methods 0.000 claims description 5
230000035897 transcription Effects 0.000 claims description 5
230000003053 immunization Effects 0.000 claims description 4
241000894007 species Species 0.000 claims description 4
206010061598 Immunodeficiency Diseases 0.000 claims description 3
230000028993 immune response Effects 0.000 claims description 3
108020004440 Thymidine kinase Proteins 0.000 claims description 2
239000013553 cell monolayer Substances 0.000 claims 1
241000700605 Viruses Species 0.000 abstract description 15
239000012634 fragment Substances 0.000 description 49
210000004027 cell Anatomy 0.000 description 35
241000700721 Hepatitis B virus Species 0.000 description 30
239000013612 plasmid Substances 0.000 description 20
230000014509 gene expression Effects 0.000 description 16
108091034117 Oligonucleotide Proteins 0.000 description 15
208000015181 infectious disease Diseases 0.000 description 13
108700026244 Open Reading Frames Proteins 0.000 description 12
101150003725 TK gene Proteins 0.000 description 12
150000001413 amino acids Chemical class 0.000 description 12
238000000246 agarose gel electrophoresis Methods 0.000 description 10
201000010099 disease Diseases 0.000 description 10
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
239000013598 vector Substances 0.000 description 10
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 8
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 8
230000015572 biosynthetic process Effects 0.000 description 8
239000002245 particle Substances 0.000 description 8
101100409044 Chlorobaculum tepidum (strain ATCC 49652 / DSM 12025 / NBRC 103806 / TLS) ppk1 gene Proteins 0.000 description 7
239000001963 growth medium Substances 0.000 description 7
210000002845 virion Anatomy 0.000 description 7
241000588724 Escherichia coli Species 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
210000003743 erythrocyte Anatomy 0.000 description 6
239000000047 product Substances 0.000 description 6
210000002966 serum Anatomy 0.000 description 6
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 5
102000003886 Glycoproteins Human genes 0.000 description 5
108090000288 Glycoproteins Proteins 0.000 description 5
108091028043 Nucleic acid sequence Proteins 0.000 description 5
230000036039 immunity Effects 0.000 description 5
102000004594 DNA Polymerase I Human genes 0.000 description 4
108010017826 DNA Polymerase I Proteins 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
239000000020 Nitrocellulose Substances 0.000 description 4
101150010882 S gene Proteins 0.000 description 4
239000011543 agarose gel Substances 0.000 description 4
239000013599 cloning vector Substances 0.000 description 4
230000002458 infectious effect Effects 0.000 description 4
229920001220 nitrocellulos Polymers 0.000 description 4
230000010076 replication Effects 0.000 description 4
230000003362 replicative effect Effects 0.000 description 4
238000001890 transfection Methods 0.000 description 4
241000282693 Cercopithecidae Species 0.000 description 3
101100409047 Chlorobaculum tepidum (strain ATCC 49652 / DSM 12025 / NBRC 103806 / TLS) ppk2 gene Proteins 0.000 description 3
108020004705 Codon Proteins 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
239000012981 Hank's balanced salt solution Substances 0.000 description 3
241000282579 Pan Species 0.000 description 3
238000010276 construction Methods 0.000 description 3
238000001514 detection method Methods 0.000 description 3
230000013595 glycosylation Effects 0.000 description 3
238000006206 glycosylation reaction Methods 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
239000006166 lysate Substances 0.000 description 3
239000000203 mixture Substances 0.000 description 3
239000002773 nucleotide Substances 0.000 description 3
125000003729 nucleotide group Chemical group 0.000 description 3
230000001681 protective effect Effects 0.000 description 3
230000006798 recombination Effects 0.000 description 3
238000005215 recombination Methods 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
238000011144 upstream manufacturing Methods 0.000 description 3
230000003612 virological effect Effects 0.000 description 3
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
108020005029 5' Flanking Region Proteins 0.000 description 2
WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 2
101000713368 Bovine immunodeficiency virus (strain R29) Protein Tat Proteins 0.000 description 2
241000288951 Callithrix <genus> Species 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
101100136728 Cricetulus griseus Pisd gene Proteins 0.000 description 2
102000053602 DNA Human genes 0.000 description 2
239000003298 DNA probe Substances 0.000 description 2
101000896148 Enterobacteria phage T4 Baseplate central spike complex protein gp27 Proteins 0.000 description 2
101000597227 Escherichia phage Mu Probable terminase, small subunit gp27 Proteins 0.000 description 2
101000912555 Escherichia phage lambda Tail fiber protein Proteins 0.000 description 2
101000764556 Haemophilus phage HP1 (strain HP1c1) Probable tape measure protein Proteins 0.000 description 2
241000709721 Hepatovirus A Species 0.000 description 2
241000725303 Human immunodeficiency virus Species 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
238000002105 Southern blotting Methods 0.000 description 2
241000700618 Vaccinia virus Species 0.000 description 2
108020005202 Viral DNA Proteins 0.000 description 2
230000001154 acute effect Effects 0.000 description 2
125000000539 amino acid group Chemical group 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
239000000427 antigen Substances 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
238000003556 assay Methods 0.000 description 2
230000000903 blocking effect Effects 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
210000002950 fibroblast Anatomy 0.000 description 2
239000000499 gel Substances 0.000 description 2
208000002672 hepatitis B Diseases 0.000 description 2
238000009396 hybridization Methods 0.000 description 2
238000002649 immunization Methods 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
238000002955 isolation Methods 0.000 description 2
229920002401 polyacrylamide Polymers 0.000 description 2
230000004481 post-translational protein modification Effects 0.000 description 2
238000011084 recovery Methods 0.000 description 2
239000000523 sample Substances 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
230000014621 translational initiation Effects 0.000 description 2
DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
108020005065 3' Flanking Region Proteins 0.000 description 1
101150007523 32 gene Proteins 0.000 description 1
101150096316 5 gene Proteins 0.000 description 1
WOVKYSAHUYNSMH-UHFFFAOYSA-N BROMODEOXYURIDINE Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-UHFFFAOYSA-N 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
108700016947 Bos taurus structural-GP Proteins 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
241000288950 Callithrix jacchus Species 0.000 description 1
101710132601 Capsid protein Proteins 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
241000700199 Cavia porcellus Species 0.000 description 1
208000034657 Convalescence Diseases 0.000 description 1
102100031673 Corneodesmosin Human genes 0.000 description 1
101710139375 Corneodesmosin Proteins 0.000 description 1
241000701022 Cytomegalovirus Species 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
101800001466 Envelope glycoprotein E1 Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
206010016654 Fibrosis Diseases 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
101710170470 Glycoprotein 42 Proteins 0.000 description 1
208000007514 Herpes zoster Diseases 0.000 description 1
241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
241000701074 Human alphaherpesvirus 2 Species 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
101710180643 Leishmanolysin Proteins 0.000 description 1
241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
102000003792 Metallothionein Human genes 0.000 description 1
108090000157 Metallothionein Proteins 0.000 description 1
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
108020005161 RNA Caps Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
241000725643 Respiratory syncytial virus Species 0.000 description 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
101710172711 Structural protein Proteins 0.000 description 1
101800001271 Surface protein Proteins 0.000 description 1
108010008038 Synthetic Vaccines Proteins 0.000 description 1
230000024932 T cell mediated immunity Effects 0.000 description 1
102000006601 Thymidine Kinase Human genes 0.000 description 1
101800000385 Transmembrane protein Proteins 0.000 description 1
108700005077 Viral Genes Proteins 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000008901 benefit Effects 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
230000007969 cellular immunity Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
229960000359 chromic chloride Drugs 0.000 description 1
LJAOOBNHPFKCDR-UHFFFAOYSA-K chromium(3+) trichloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Cl-].[Cr+3] LJAOOBNHPFKCDR-UHFFFAOYSA-K 0.000 description 1
235000007831 chromium(III) chloride Nutrition 0.000 description 1
239000011636 chromium(III) chloride Substances 0.000 description 1
230000007882 cirrhosis Effects 0.000 description 1
208000019425 cirrhosis of liver Diseases 0.000 description 1
239000000470 constituent Substances 0.000 description 1
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
230000007423 decrease Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
231100000676 disease causative agent Toxicity 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
238000012869 ethanol precipitation Methods 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
239000013613 expression plasmid Substances 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
206010073071 hepatocellular carcinoma Diseases 0.000 description 1
230000006801 homologous recombination Effects 0.000 description 1
238000002744 homologous recombination Methods 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
201000006747 infectious mononucleosis Diseases 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
230000002045 lasting effect Effects 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
210000005229 liver cell Anatomy 0.000 description 1
208000019423 liver disease Diseases 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
239000012528 membrane Substances 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
230000002969 morbid Effects 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
239000000902 placebo Substances 0.000 description 1
229940068196 placebo Drugs 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
229940124551 recombinant vaccine Drugs 0.000 description 1
238000011160 research Methods 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
210000003935 rough endoplasmic reticulum Anatomy 0.000 description 1
239000002356 single layer Substances 0.000 description 1
210000003594 spinal ganglia Anatomy 0.000 description 1
229940031626 subunit vaccine Drugs 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
238000012360 testing method Methods 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000013519 translation Methods 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
238000002255 vaccination Methods 0.000 description 1
210000003501 vero cell Anatomy 0.000 description 1
230000029812 viral genome replication Effects 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
229960004854 viral vaccine Drugs 0.000 description 1
238000003260 vortexing Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Biophysics (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

IL8285187A 1986-06-20 1987-06-11 נגיף ואריצלה - זוסטר שטבעו שונה, ייצורו ותרכיב המכיל אותו IL82851A (he)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US87695686A	1986-06-20	1986-06-20

Publications (2)

Publication Number	Publication Date
IL82851A0 IL82851A0 (en)	1987-12-20
IL82851A true IL82851A (he)	1995-01-24

Family

ID=25368939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL8285187A IL82851A (he)	1986-06-20	1987-06-11	נגיף ואריצלה - זוסטר שטבעו שונה, ייצורו ותרכיב המכיל אותו

Country Status (14)

Country	Link
EP (1)	EP0251534B1 (he)
JP (1)	JP2523132B2 (he)
KR (1)	KR960008674B1 (he)
AT (1)	ATE93543T1 (he)
AU (1)	AU601747B2 (he)
CA (1)	CA1337596C (he)
DE (1)	DE3787131T2 (he)
DK (1)	DK312687A (he)
ES (1)	ES2058116T3 (he)
IE (1)	IE60898B1 (he)
IL (1)	IL82851A (he)
NZ (1)	NZ220645A (he)
PT (1)	PT85108B (he)
ZA (1)	ZA874434B (he)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3706233A1 (de) *	1987-02-26	1988-09-08	Behringwerke Ag	Immunogene fusionsproteine, die epstein-barr-virusproteine enthalten
US5324664A (en) *	1988-08-08	1994-06-28	The Upjohn Company	Herpes virus thymidien kinase-encoding DNA
ATE130631T1 (de) *	1988-08-08	1995-12-15	Upjohn Co	Verfahren zur isolierung für thymidin-kinase der herpesvirus kodierenden dns.
JP3026029B2 (ja) *	1991-04-26	2000-03-27	財団法人阪大微生物病研究会	組換え水痘ウイルスとその作製法
ES2165367T5 (es)	1992-07-17	2009-08-05	MERCK & CO., INC.	Procedimiento para prevenir el herpes zoster o para aliviar la neuralgia post-herpetica relacionada con la varicela.
JPH09506777A (ja) *	1993-12-21	1997-07-08	メルクエンドカンパニーインコーポレーテッド	熱安定性の水痘帯状疱疹ウイルス
FR2952825B1 (fr)	2009-11-24	2012-05-25	Goaster Jacqueline Le	Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5341202B2 (he) *	1974-03-12	1978-11-01
US4603112A (en) *	1981-12-24	1986-07-29	Health Research, Incorporated	Modified vaccinia virus
CA1282721C (en) *	1984-06-04	1991-04-09	Bernard Roizman	Herpes simplex virus as a vector
AU576907B2 (en) *	1984-11-01	1988-09-08	American Home Products Corporation	Oral vaccines comprising live recombinant adenoviruses

1987
- 1987-06-10 NZ NZ220645A patent/NZ220645A/xx unknown
- 1987-06-11 IL IL8285187A patent/IL82851A/he not_active IP Right Cessation
- 1987-06-12 DE DE87305202T patent/DE3787131T2/de not_active Expired - Fee Related
- 1987-06-12 AT AT87305202T patent/ATE93543T1/de not_active IP Right Cessation
- 1987-06-12 EP EP87305202A patent/EP0251534B1/en not_active Expired - Lifetime
- 1987-06-12 ES ES87305202T patent/ES2058116T3/es not_active Expired - Lifetime
- 1987-06-16 CA CA000539785A patent/CA1337596C/en not_active Expired - Fee Related
- 1987-06-17 PT PT85108A patent/PT85108B/pt not_active IP Right Cessation
- 1987-06-19 IE IE163987A patent/IE60898B1/en not_active IP Right Cessation
- 1987-06-19 KR KR1019870006210A patent/KR960008674B1/ko not_active IP Right Cessation
- 1987-06-19 AU AU74492/87A patent/AU601747B2/en not_active Ceased
- 1987-06-19 ZA ZA874434A patent/ZA874434B/xx unknown
- 1987-06-19 DK DK312687A patent/DK312687A/da not_active Application Discontinuation
- 1987-06-19 JP JP62151539A patent/JP2523132B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
KR880000579A (ko)	1988-03-26
IE871639L (en)	1987-12-20
CA1337596C (en)	1995-11-21
DE3787131T2 (de)	1994-02-03
NZ220645A (en)	1989-10-27
AU7449287A (en)	1987-12-24
ZA874434B (en)	1987-12-21
KR960008674B1 (ko)	1996-06-28
EP0251534B1 (en)	1993-08-25
JP2523132B2 (ja)	1996-08-07
DK312687A (da)	1988-03-10
ES2058116T3 (es)	1994-11-01
IE60898B1 (en)	1994-08-24
DK312687D0 (da)	1987-06-19
EP0251534A1 (en)	1988-01-07
PT85108B (pt)	1990-03-08
IL82851A0 (en)	1987-12-20
ATE93543T1 (de)	1993-09-15
DE3787131D1 (de)	1993-09-30
PT85108A (en)	1987-07-01
JPS6312277A (ja)	1988-01-19
AU601747B2 (en)	1990-09-20

Publication	Publication Date	Title
US5310668A (en)	1994-05-10	Varicella-zoster virus as a live recombinant vaccine
JP3083839B2 (ja)	2000-09-04	ヘルペスウイルス組換えポックスウイルスワクチン
AU701781B2 (en)	1999-02-04	ALVAC canarypox virus recombinants comprising heterologous inserts
US5314808A (en)	1994-05-24	Method for the transformation of cells, particularly eukaryotes by a DNA originating from viruses of hepatitis, more particularly from virus of a B viral hepatitis, and preparations containing the expression products of said DNAs
JPH08253428A (ja)	1996-10-01	膜結合性タンパク質を含有するワクチン類
LU88000A1 (fr)	1992-03-11	Systeme de selection d'hotes de poxvirus du recombinaision
PT752888E (pt)	2007-11-13	''sequencias de nucleótidos e de aminoácidos de gb, gc e gd de herpesvírus canino e suas utilizações''
US6051426A (en)	2000-04-18	Vectors for transforming CHO cells
CA1337596C (en)	1995-11-21	Varicella-zoster virus as a live recombinant vaccine
CA2182888C (en)	2007-08-07	Nucleotide and amino acid sequences of canine herpesvirus gb, gc and gd and uses therefor
CA2223419A1 (en)	1996-12-12	Recombinant poxvirus-calicivirus [rabbit hemorrhagic disease virus (rhdv)] compositions and uses
AU4315689A (en)	1990-03-23	Defective hepadnaviruses and producer cell line for vaccines and treatment of liver diseases and disorders
Yu et al.	1998	The GDPAL region of the pre-S1 envelope protein is important for morphogenesis of woodchuck hepatitis virus
AU701599B2 (en)	1999-02-04	TROVAC fowlpox virus recombinants comprising heterologous inserts
NL195085C (nl)	2003-11-13	Herpesvirus recombinant pokkenvirus.
AU747139B2 (en)	2002-05-09	Immunodeficiency recombinant poxvirus
Epstein	1989	Recent progress with vaccines against Epstein-Barr virus infection

Legal Events

Date	Code	Title
1997-09-30	KB	Patent renewed
2001-07-24	KB	Patent renewed
2006-03-12	MM9K	Patent not in force due to non-payment of renewal fees